Clinical Trial Update: A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain [Phase 2, Phase 3]

View source ↗

Summary

This update reports the results of a Phase 2/3 dose-finding study of the fentanyl JNS020 QD 1-day transdermal patch in cancer-related pain, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cancer Pain

Drugs mentioned

• Fentanyl transdermal patch (JNS020 QD) (fentanyl)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pain, Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-05-21